AXIM BIOTECHNOLOGIES INC AXIM
$0.00
+0.00%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | PRIMARY DOCUMENT | 2024-10-15 | View → |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 2024-10-15 | View → |
| 10-Q | FORM 10-Q | 2024-08-19 | View → |
| 10-Q | FORM 10-Q | 2024-05-20 | View → |
| 10-K | FORM 10-K | 2024-04-16 | View → |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 2024-03-21 | View → |
| 4 | PRIMARY DOCUMENT | 2024-03-19 | View → |
| 4 | PRIMARY DOCUMENT | 2024-03-19 | View → |
| 4 | PRIMARY DOCUMENT | 2024-03-19 | View → |
| 4 | PRIMARY DOCUMENT | 2024-03-19 | View → |
| 4 | PRIMARY DOCUMENT | 2024-03-19 | View → |
| 4 | PRIMARY DOCUMENT | 2024-03-19 | View → |
| 4 | PRIMARY DOCUMENT | 2024-03-19 | View → |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 2024-02-13 | View → |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 2023-12-28 | View → |
| 10-Q | FORM 10-Q | 2023-11-20 | View → |
| 10-Q | AXIM BIOTECHNOLOGIES FORM 10-Q | 2023-08-21 | View → |
| S-1 | FORM S-1 | 2023-06-02 | View → |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 2023-06-02 | View → |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 2023-05-30 | View → |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 2023-05-25 | View → |
| 10-Q | FORM 10-Q | 2023-05-22 | View → |
| 10-K | FORM 10-K | 2023-04-17 | View → |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 2023-01-27 | View → |
| 10-Q | FORM 10-Q | 2022-11-14 | View → |
| 4 | PRIMARY DOCUMENT | 2022-09-23 | View → |
| 4 | PRIMARY DOCUMENT | 2022-09-23 | View → |
| 4 | PRIMARY DOCUMENT | 2022-09-23 | View → |
| 4 | PRIMARY DOCUMENT | 2022-09-23 | View → |
| 4 | PRIMARY DOCUMENT | 2022-09-23 | View → |
| 4 | PRIMARY DOCUMENT | 2022-09-23 | View → |
| 4 | PRIMARY DOCUMENT | 2022-09-23 | View → |
| 4 | PRIMARY DOCUMENT | 2022-09-23 | View → |
| 4 | PRIMARY DOCUMENT | 2022-09-23 | View → |
| 4 | PRIMARY DOCUMENT | 2022-09-23 | View → |
| 4 | PRIMARY DOCUMENT | 2022-09-23 | View → |
| 4 | PRIMARY DOCUMENT | 2022-09-23 | View → |
| SC 13D | SCHEDULE 13D - JUNIPER & IVY CORP | 2022-09-23 | View → |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 2022-09-19 | View → |
| 4 | PRIMARY DOCUMENT | 2022-08-31 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $0.00
- Market Cap
- —
- 52-Week Range
- $0.00 – $0.03
- Average Volume
- 174K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
